Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...
Roche is hoping to undercut hugely expensive rivals after the FDA approved its oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam). Evrysdi is the third treatment approved for SMA, an ...
SMA Solar Technology AG, together with its subsidiaries, develops, produces, and sells PV and battery inverters, monitoring systems for PV systems, and charging solutions for electric vehicles in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results